Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): New Obesity Drug Hits the Market
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)' Belviq, the newest offering, looks relatively safe.
Posts Tagged ‘NASDAQ:ARNA’
Johnson & Johnson (JNJ), VIVUS, Inc. (VVUS): The Three Biggest Risk Factors for a Stroke
Often referred to as "the silent killer," stroke is the fourth-leading cause of the death in the U.S., behind only heart disease, cancer, and chronic lower respiratory diseases...
Arena Pharmaceuticals, Inc. (ARNA): Hedge Funds Are Bullish and Insiders Are Bearish, What Should You Do?
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 13 hedge funds' portfolio at the end of the first quarter of 2013.
Arena Pharmaceuticals, Inc. (ARNA): The Short Data You Need To See
Nowadays, there are a multitude of indicators for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) readers to pay attention to, but it's key to monitor a stock's short sellers.
Infosys Ltd ADR (INFY), Teva Pharmaceutical Industries Ltd (ADR) (TEVA), Marathon Petroleum Corp (MPC): Three Intriguing Plays This Hedge Fund Is Focusing On
Editor's Note: Related tickers: Infosys Ltd ADR (NYSE:INFY), Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Marathon Petroleum Corp (NYSE:MPC), VIVUS, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): The 7 Most Obese U.S. States
The U.S., which ranks as the most obese nation in the world according to the Organization for Economic Cooperation and Development, has seen a relatively steady increase over ...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): This Obesity Drugmaker Is Badly In Need of a Marketing Partner
As recently as a decade ago, the biggest hurdle for biotech companies wasn't competition from their peers or even the sale price of their drugs.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) Are NOT The Newest Obesity Drug Player
VIVUS, Inc. (NASDAQ:VVUS) and Arena Pharmaceuticals, Inc.
Three Big Reasons to Own Johnson & Johnson (JNJ) Stock
When investors are looking to fill out their retirement portfolios, they would be wise to give a long, hard look at Johnson & Johnson (NYSE:JNJ) stock.
Dunkin Brands Group Inc (DNKN), McDonald’s Corporation (MCD): The Seven Least Obese U.S. States
With the Organisation for Economic Co-operation and Development pinpointing the United States as the most obese country in the world, it can be hard to find many positives with...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The Top Three Causes of Diabetes
A whopping 25.3 million people in the U.S. right now are diabetic, with an additional 79 million Americans in the pre-diabetes stage.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Why This Obesity Drug Is the Sector’s Best Bet
Editor's Note: The original article incorrectly stated Schedule IV drugs are the second-most-restrictive.
Arena Pharmaceuticals, Inc. (ARNA): Why This Obesity Drug Is the Sector’s Best Bet
The obesity drug space is becoming increasingly complex and hard to predict. After months of waiting patiently, Arena Pharmaceuticals, Inc.
Orexigen Therapeutics, Inc. (OREX), And Three Pipeline Obesity Treatments You Should Watch
Obesity is a growing pandemic for many industrialized nations, especially in the U.S., where it now affects almost 36% of adults and 17% of adolescents.
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY), Johnson & Johnson (JNJ): The Surprising Link Between ADHD and Obesity
The study tracked men with ADHD for more than 30 years and found that a whopping 41% of them were obese compared to 22% of patients in a matched control group who didn't have ...
Whole Foods Market (WFM), Chipotle Mexican Grill, Inc. (CMG): The 9 Most Obese Countries in the World
The rate of worldwide obesity has been marching higher at an extraordinary rate for more than three decades now.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): What To Know About Obesity
The Food and Drug Administration approved the weight-loss therapy Belviq from Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in June 2012.
Arena Pharmaceuticals, Inc. (ARNA), Vivus, Inc. (VVUS) & Orexigen Therapeutics, Inc. (OREX): What’s Weight Loss For Now?
It wasn't that long ago that obesity drugs were considered a lifestyle drug. Doctors, the Food and Drug Administration, and insurers believed losing weight was a vanity issue.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): A Belviq Battle
Things are beginning to look slightly up for obesity drugmaker VIVUS, Inc. (NASDAQ:VVUS) -- mere weeks before a competing drug from Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA): The Mystery Objectors
Short interest in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is 28.81% of its float.
Arena Pharmaceuticals, Inc. (ARNA): You Need To See These 5 Points
A sharp drop in Arena Pharmaceuticals (NASDAQ:ARNA) followed after the company reported quarterly earnings and a withdrawal of its Marketing Authorization Application (“MAA”) ...
Infinity Pharmaceuticals Inc. (INFI): Watch This Data
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) was in 22 hedge funds' portfolio at the end of December. INFI has experienced an increase in enthusiasm from smart money of late.
VIVUS, Inc. (VVUS): You’ve Got To Spend Money To Make Money
VIVUS, Inc. (NASDAQ:VVUS) has the first part down.
Pfizer Inc. (PFE), Johnson & Johnson (JNJ): The Next Frontier?
Only 19 drugs have ever netted at least $5 billion in annual sales -- and most were at their peak --according to a list compiled by Simon King of Forbes earlier this year.
Arena Pharmaceuticals, Inc. (ARNA): The Mind-Blowing Data You Missed
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a healthy stock for your portfolio? Money managers are taking a bullish view.
Arena Pharmaceuticals, Inc. (ARNA): This Could Be A Major Blockbuster
It's been a long road, but Eisai and Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)' obesity drug Belviq can finally launch in 30 days.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) & Orexigen Therapeutics, Inc. (OREX): The Bottom Line
VIVUS, Inc. (NASDAQ:VVUS)' Qsymia has not received the unconditional consumer love that investors were hoping.
Merck & Co., Inc. (MRK), AVEO Pharmaceuticals, Inc. (AVEO): This Week in Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it's evident that investment dollars are willingly flowing into the biotech sector.
Arena Pharmaceuticals, Inc. (ARNA): U.S. Approved Obesity Drug Derailed in EU
Most, and probably all, of that decline is because of the European decision, or lack thereof. Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (ARNA): Here’s What You Missed
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS), Orexigen Therapeutics, Inc. (OREX): Have Drugmakers Found the Panacea for Obesity? (Part I)
After a gap of several years, there seems to be a candidate in the obesity drug market that could turn out to be a long-term winner.
Biopharma News: Arena Pharmaceuticals, Inc. (ARNA)’s Update, New VIVUS, Inc. (VVUS) Deal & More
Editor's Note: Related tickers: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), VIVUS, Inc. (NASDAQ:VVUS), Johnson & Johnson (NYSE:JNJ), Orexigen Therapeutics, Inc.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS) & The Panacea For Obesity?
In the previous part of this article, I discussed the potential obesity market and some promising drugs on the scene.
Regeneron Pharmaceuticals Inc (REGN), Sanofi SA (SNY), Arena Pharmaceuticals, Inc. (ARNA) & Three Companies Ripe for a Takeover
One of the nice things about owning biotech companies is the large number of acquisitions in the sector.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA) & Some Key Catalysts Approaching
The obesity stocks are perhaps some of the most discussed and followed stocks in the entire biotechnology sector.
Arena Pharmaceuticals, Inc. (ARNA): One Mind-Blowing Metric Screaming ‘Buy’
Is Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) an exceptional investment now? Prominent investors are taking a bullish view.
Trending News: Exxon Mobil Corporation (XOM), Arena Pharmaceuticals, Inc. (ARNA), QUALCOMM, Inc. (QCOM)
Editor's Note: Related tickers: Exxon Mobil Corporation (NYSE:XOM), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), 3M Co (NYSE:MMM), Akamai Technologies, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Anti-Obesity Stocks Are Attractively Priced
The obesity market was one of the most attractive sectors a year ago, and the shares of companies developing anti-obesity drugs were the pharmaceutical sector's hottest properties...
Herbalife Ltd. (HLF), Arena Pharmaceuticals, Inc. (ARNA), Vivus, Inc. (VVUS): Stocks to Know for the Obesity Epidemic
Obesity rates have been steadily growing in the developed world, in particular in the US, which has the world’s highest rate of obesity.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): The US’s Hidden Obesity Epidemic
The United States is the fattest country in the world -- and I'm not talking about our wallets, folks! According to the Centers for Disease Control and Prevention, a disheartening...
Theravance Inc (THRX): Here’s One Thing To Know About The Stock Today
Theravance Inc (NASDAQ:THRX) has experienced a decrease in support from the world's most elite money managers of late, but insiders on the whole appear bullish.
Arena Pharmaceuticals, Inc. (ARNA), Biogen Idec Inc. (BIIB): More Than an Obesity Drug Company
Arena Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), and How Doctors Actually Diagnose Obesity
The obesity crisis in America is a hotly debated topic. According to the Centers for Disease Control and Prevention, more than 35% of adults in the U.S.
Do Hedge Funds and Insiders Love Arena Pharmaceuticals, Inc. (ARNA)?: Charles River Laboratories (CRL), Synageva BioPharma Corp (GEVA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) was in 11 hedge funds' portfolio at the end of the fourth quarter of 2012.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Ten Flabbergasting Costs of America’s Obesity Epidemic
Obesity is costing us big time. Three times more Americans are obese now than were in 1960. Six times more Americans are now extremely obese than a half-century ago.
Arena Pharmaceuticals, Inc. (ARNA), VIVUS, Inc. (VVUS): Which Obesity Drug Will Boost Your Portfolio?
In 2012, the FDA approved two obesity drugs for use in the United States. One drug, named "Belviq", is from Arena Pharmaceuticals, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA), Orexigen Therapeutics, Inc. (OREX): The Big Weight-Drug Wait
"Wait" seems to be the operative word for the obesity drug industry these days. Investors in VIVUS, Inc.
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): Is Obesity Really a Dangerous Disease?
Obesity drugmakers Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) , VIVUS, Inc. (NASDAQ:VVUS) , and Orexigen Therapeutics, Inc.
